Kennedy MS. Comprehensive care in the allergy/asthma office: evaluation of chronic eczema and urticaria and angioedema. Immunol Allergy Clin North Am. 1999;19(1):19-33
Alper BS. SOAP: solutions to often asked problems. Choice of antihistamines for urticaria. Arch Fam Med. 2000 Aug;9(8):748-751. http://www.ncbi.nlm.nih.gov/pubmed/?term=Alper+BS%09Choice+of+antihistamines+for+urticaria. PMID: 10927716
Baxi S, Dinakar C. Urticaria and angioedema. Immunol Allergy Clin North Am. 2005 May;25(2):353-367. http://www.ncbi.nlm.nih.gov/pubmed/?term=Baxi+S%2C+Dinakar+C%09Urticaria+and+angioedema. PMID: 15878460
Blauvelt A, Hwang ST, Udey MC. 11. Allergic disorders: allergic and immunologic diseases of the skin. J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S560-S570. http://www.ncbi.nlm.nih.gov/. PMID: 12592302
Chow SK. Management of chronic urticaria in Asia: 2010 AADV consensus guidelines. Asia Pac Allergy. 2012 Apr;2(2):149-160. doi: 10.5415/apallergy.2012.2.2.149. Accessed 16 Sep 2013. PMID: 22701866
Grattan C, Humphreys F, on behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol. 2007 Dec;157(6):1116-1123. http://www.ncbi.nlm.nih.gov/pubmed/18021095. PMID: 18021095
Grattan C, Powell S, Humphreys F. Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol. 2001 Apr;144(4):708-714. http://www.ncbi.nlm.nih.gov/pubmed/?term=11298527. PMID: 11298527
Konstantinou GN, Asero R, Ferrer M, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy. 2013 Jan;68(1):27-36. doi: 10.1111/all.12056. PMID: 23157716
Monroe E, Finn A, Patel P, et al. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol. 2003 Apr;48(4):535-541. http://www.ncbi.nlm.nih.gov/pubmed/?term=12664016. PMID: 12664016
Leung DY, Boguniewicz M. Advances in allergic skin diseases. J Allergy Clin Immunol. 2003 Mar;111(Suppl 3):S805-S812. http://www.ncbi.nlm.nih.gov/pubmed/?term=Leung+DY%2C+Boguniewicz+M%09Advances+in+allergic+skin+diseases. PMID: 12618747
Muller BA. Urticaria and angioedema: a practical approach. Am Fam Physician. 2004 Mar;69(5):1123-1128. https://www.aafp.org. PMID: 15023012
Poonawalla T, Kelly B. Urticaria - a review. Am J Clin Dermatol. 2009;10(1):9-21. doi: 10.2165/0128071-200910010-00002. Accessed 21 Jan 2011. PMID: 19170406
Nichols K, Cook-Bolden F. Allergic skin disease: major highlights and recent advance. Med Clin Am. 2009 Nov;93(6):1211-1224. doi: 10.1016/j.mcna.2009.08.004. PMID: 19932327
Zacharisen MC. Pediatric allergy and immunology: pediatric urticaria and angioedema. Immunol Allergy Clin North Am. 1999 Dec;19(2):363-382. doi: 10.1016/S1081-1206(10)62866-9. PMID: 10619346
Bingham C. New onset urticaria: epidemiology, clinical manifestations, and etiologies. UpToDate. https://www.uptodate.com. 17 Sep 2010. Accessed 20 Dec 2010.
American Academy of Allergy, Asthma and Immunology. Omalizumab: well tolerated and effective in refractory chronic idiopathic/spontaneous urticaria. AAAAI. https://www.aaaai.org/. Jul 2013. Accessed 16 Sep 2013.
Linscott MS, Crawford MB. Urticaria. eMedicine. http://www.emedicine.com/emerg/topic628.htm.Monroe. 12 Jun 2006. Accessed 12 Jun 2006.
Powell RJ, Leech SC, Till S, et al; British Society for Allergy and Clinical Immunology. BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy. 2015 Mar;45(3):547-565. doi: 10.1111/cea.12494. Accessed 8 Jan 2016. PMID: 25711134
Antia C, Baquerizo K, Korman A, et al. Urticaria: a comprehensive review. J Am Acad Dermatol. 2018 Oct;79(4):617-633. doi: 10.1016/j.jaad.2018.01.023. Accessed 13 Mar 2019. PMID: 30241624
Asero R. New-onset urticaria. UpToDate. https://www.uptodate.com. 2019. Accessed 13 Mar 2019.
Khan DA. Chronic spontaneous urticaria: standard management and patient education. UpToDate. https://www.uptodate.com. 2019. Accessed 13 Mar 2019.
Khan DA. Chronic spontaneous urticaria: treatment of refractory symptoms. UpToDate. https://www.uptodate.com. 2019. Accessed 13 Mar 2019.
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018 Jul;73(7):1393-1414. doi: 10.1111/all.13397. Accessed 11 Feb 2019. PMID: 29336054
Zuberbier T, Bernstein JA. A comparison of the United States and international perspective on chronic urticaria guidelines. J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1144-1151. doi: 10.1016/j.jaip.2018.04.012. Accessed 13 Mar 2019. PMID: 29779967
Australasian Society of Clinical Immunology and Allergy (ASCIA). Position paper - chronic spontaneous urticaria (CSU). ASCIA. https://www.allergy.org.au/. 2020.
Maurer M, Eyerich K, Eyerich S, et al. Urticaria: Collegium Internationale Allergologicum (CIA) update 2020. Int Arch Allergy Immunol. 2020 Mar;181(5):321-333. doi: 10.1159/000507218. Accessed 15 Feb 2021. PMID: 32224621
Magerl M, Altrichter S, Borzova E, et al. The definition, diagnostic testing, and management of
chronic inducible urticarias – The EAACI/GA²LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy. 2016 Jun;71(6):780-802. doi: 10.1111/all.12884. Accessed 28 Jan 2022. PMID: 26991006
Zuberbier T, Latiff AHA, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022 Mar;77(3):734-766. doi: 10.1111/all.15090. Accessed 24 Jan 2022. PMID: 34536239
Kaplon H, Chenoweth A, Crescioli S, et al. Antibodies to watch in 2022. MAbs. 2022 Jan-Dec;14(1):2014296. doi: 10.1080/19420862.2021.2014296. Accessed 16 Apr 2022. PMID: 35030985
Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014 May;133(5):1270-1277. http://www.aaaai.org. PMID: 24766875
Cho YT, Chan TC, Lee CH, et al. Taiwanese dermatological association consensus for the definition, classification, diagnosis, and management of urticaria: a 2021 update. J Formos Med Assoc. 2022 Jul;121(7):1191-1203. doi: 10.1016/j.jfma.2022.02.007. Accessed 11 Apr 2023. PMID: 35219557
Zuberbier T, Altrichter S, Bauer S, et al. S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria - German-language adaptation of the international S3 Guideline. J Dtsch Dermatol Ges. 2023 Jan;21(1):81-93. doi: 10.1111/ddg.14906. PMID: 36721941
Fricke J, Avila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis. Allergy. 2020;75(2):423-432. doi: 10.1111/all.14037 . PMID: 31494963
Peck G, Hashim M J, Shaughnessy C, et al. Global epidemiology of urticaria: Increasing burden among children, females and low-income regions. Acta Derm Venereol. 2021;101(4):adv00433. doi: 10.2340/00015555-3796. Accessed 16 May 2025. PMID: 33847367
Zhao Z, Huang Y, Chen D, Wang Y. Global health implications of urticaria burden (1990–2021): a comprehensive analysis of trends across nations and regions. Archives of Medical Science. https://www.archivesofmedicalscience.com. 2025.